Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PWSL | ISIN: US74365A3095 | Ticker-Symbol: PBDA
Tradegate
25.03.24
20:04 Uhr
1,145 Euro
-0,005
-0,43 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
PROTALIX BIOTHERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
PROTALIX BIOTHERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,1501,19620:30
1,1511,19520:21

Aktuelle News zur PROTALIX BIOTHERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.03.Protalix BioTherapeutics, Inc. (PLX) Q4 2023 Earnings Call Transcript1
15.03.Earnings call: Protalix BioTherapeutics reports fiscal year 2023 results4
14.03.Protalix BioTherapeutics, Inc. - 10-K, Annual Report2
14.03.Protalix BioTherapeutics GAAP EPS of $0.09 misses by $0.01, revenue of $65.49M beats by $1.54M4
14.03.Protalix BioTherapeutics, Inc. - 8-K, Current Report1
14.03.Protalix BioTherapeutics, Inc.: Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results114Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel, March 14, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company...
► Artikel lesen
13.03.Earnings Preview: Protalix BioTherapeutics1
13.03.Protalix BioTherapeutics FY Earnings Preview2
26.12.23Protalix BioTherapeutics, Inc. - 8-K, Current Report6
06.11.23American Well, Protalix BioTherapeutics among healthcare movers10
06.11.23Protalix BioTherapeutics, Inc. - 10-Q, Quarterly Report2
06.11.23Protalix BioTherapeutics, Inc. - 8-K, Current Report2
06.11.23Protalix BioTherapeutics Inc. Q3 loss drops in line with estimates325JERUSALEM (dpa-AFX) - Protalix BioTherapeutics Inc. (PLX) released Loss for third quarter that decreased from the same period last year in line with the Street estimates.The company's bottom...
► Artikel lesen
06.11.23Protalix BioTherapeutics GAAP EPS of -$0.04 beats by $0.03, revenue of $10.35M beats by $2.71M9
06.11.23Protalix BioTherapeutics, Inc.: Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results186Company to host conference call and webcast today at 8:30 a.m. EST CARMIEL, Israel, Nov. 6, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company...
► Artikel lesen
03.11.23Earnings Preview For Protalix BioTherapeutics3
03.11.23Protalix BioTherapeutics Q3 Earnings Preview3
23.10.23Protalix BioTherapeutics And 2 Other Penny Stocks Insiders Are Buying4
20.10.23Palatin Technologies, Protalix BioTherapeutics, Arcutis among healthcare movers44
12.09.23Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman493WASHINGTON (dpa-AFX) - Biopharmaceutical company Protalix BioTherapeutics, Inc. (PLX) announced Tuesday that the Company's Board of Directors has appointed Eliot Richard Forster to serve on...
► Artikel lesen
Seite:  Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1